US Patent 9962436 Multimeric fusion protein vaccine and immunotherapeutic
Patent 9962436 was granted and assigned to The Henry M. Jackson Foundation For The Advancement Of Military Medicine on May, 2018 by the United States Patent and Trademark Office.